Alamandine reverses hyperhomocysteinemia-induced vascular dysfunction via PKA-dependent mechanisms
Download
Download
Download![[img]](https://vuir.vu.edu.au/style/images/fileicons/text.png)
Qaradkhi_et al 2017_Manuscript.docx_REVISED copy.docx
- Submitted Version
(160kB)
Restricted to Repository staff only
Export
Qaradakhi, T, Matsoukas, MT, Hayes, Alan 
ORCID: 0000-0003-1398-3694, Rybalka, Emma ORCID: 0000-0002-4854-0036, Caprnda, M, Rimarova, K, Sepsi, M, Büsselberg, Dietrich, Kruzliak, P, Matsoukas, J, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Zulli, Anthony ORCID: 0000-0002-2660-078X
(2017)
Alamandine reverses hyperhomocysteinemia-induced vascular dysfunction via PKA-dependent mechanisms.
Cardiovascular Therapeutics, 35 (6).
ISSN 1755-5914
Dimensions Badge
Altmetric Badge
| Item type | Article |
| URI | https://vuir.vu.edu.au/id/eprint/34789 |
| DOI | https://doi.org/10.1111/1755-5922.12306 |
| Official URL | http://onlinelibrary.wiley.com/doi/10.1111/1755-59... |
| Subjects | Current > FOR Classification > 1116 Medical Physiology Current > Division/Research > College of Health and Biomedicine |
| Keywords | atherosclerosis; endothelial dysfunction; protein kinase A; MrgD; HHcy |
| Citations in Scopus | 15 - View on Scopus |
| Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)